Complete radiological response of metastatic anaplastic lymphoma kinase-positive signet ring lung adenocarcinoma to systemic chemotherapy

Journal of Thoracic Oncology

Volumn 6, Issue 5, 2011, Pages 963-965

  Korpanty, Grzegorz ^a   Mulligan, Niall ^a   Carney, Desmond N ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CARBOPLATIN; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4; MICROTUBULE ASSOCIATED PROTEIN; PEMETREXED; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHOSCOPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SIZE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG TOLERABILITY; EMERGENCY WARD; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG LAVAGE; LYMPHADENOPATHY; MEDIASTINUM LYMPH NODE; METASTASIS; MULTIPLE CYCLE TREATMENT; PARAAORTIC LYMPH NODE; PLEURA EFFUSION; PLEURAL PAIN; PRIORITY JOURNAL; SIGNET RING CARCINOMA; THORAX PAIN; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT RESPONSE; TUMOR NECROSIS;

EID: 79955455017     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318215a242     Document Type: Article

References (3)

1. Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4- ALK. J Clin Oncol 2009;27:4247-4253.
2. Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset. Modern Pathol 2009;22:508-515.
3. Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. New Engl J Med 2010;363: 1693-1703.